Yoon-Jeong Jeon

Title: Innovations in Cancer Treatment by Yoon-Jeong Jeon

Introduction

Yoon-Jeong Jeon is a distinguished inventor based in Daejeon, South Korea, known for his groundbreaking contributions to cancer treatment methods. With two patents to his name, Jeon focuses on enhancing the effectiveness of pharmaceuticals through innovative derivatives and compositions.

Latest Patents

Jeon's latest patents include a geranyl flavonoid derivative with improved water solubility and an associated method for treating cancer. This novel compound shows promise in inhibiting the expression of STAT3 target proteins by suppressing their phosphorylation, which in turn suggests a cancer cell growth inhibiting effect across various cancer cell lines. Moreover, his compound has proven effective in reducing tumor size and weight significantly in vivo, indicating its efficacy in cancer treatment. Another significant patent involves a pharmaceutical composition that utilizes extracts from the fruits, leaves, or stems of Artocarpus altilis for cancer prevention or treatment. This composition effectively suppresses the activity of STAT3, which plays a crucial role in cancer cell growth and immune function, demonstrating potential applications against a wide range of cancers.

Career Highlights

Yoon-Jeong Jeon works at the Korea Research Institute of Bioscience and Biotechnology, where he has dedicated his efforts to advancing biopharmaceutical innovations. His work has not only contributed to theoretical advancements but also has practical implications for cancer therapies.

Collaborations

Throughout his career, Jeon has collaborated with esteemed colleagues, including Byoung-Mog Kwon and Dong Cho Han. These collaborations have enriched his innovative projects and have played a crucial role in the development of his patented inventions.

Conclusion

Yoon-Jeong Jeon's contributions to the field of cancer treatment highlight the importance of innovation in pharmaceuticals. Through his patents, he signifies a remarkable step forward in providing effective cancer therapies, showcasing the potential of biomedical research in improving health outcomes. His work at the Korea Research Institute of Bioscience and Biotechnology continues to inspire and pave the way for future breakthroughs in cancer prevention and treatment.